In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study.
about
CD56 in the Immune System: More Than a Marker for Cytotoxicity?Current Advances in γδ T Cell-Based Tumor Immunotherapy.Cerebrospinal fluid γδ T cell frequency is age-related: a case control study of 435 children with inflammatory and non-inflammatory neurologic disorders.Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.
P2860
In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo expansion and activati ...... euroblastoma: A phase 1 study.
@en
In vivo expansion and activati ...... euroblastoma: A phase 1 study.
@nl
type
label
In vivo expansion and activati ...... euroblastoma: A phase 1 study.
@en
In vivo expansion and activati ...... euroblastoma: A phase 1 study.
@nl
prefLabel
In vivo expansion and activati ...... euroblastoma: A phase 1 study.
@en
In vivo expansion and activati ...... euroblastoma: A phase 1 study.
@nl
P2093
P2860
P1433
P1476
In vivo expansion and activati ...... neuroblastoma: A phase 1 study
@en
P2093
Julia Adams
Lawrence S Lamb
Lualhati Harkins
Zhiying You
P2860
P356
10.1097/MD.0000000000004909
P407
P577
2016-09-01T00:00:00Z